nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—hematologic cancer	0.126	1	CbGaD
Atazanavir—ABCC1—Idarubicin—hematologic cancer	0.0589	0.0995	CbGbCtD
Atazanavir—ABCC1—Daunorubicin—hematologic cancer	0.0417	0.0704	CbGbCtD
Atazanavir—ABCC1—Mitoxantrone—hematologic cancer	0.0253	0.0428	CbGbCtD
Atazanavir—ABCC1—Epirubicin—hematologic cancer	0.0205	0.0346	CbGbCtD
Atazanavir—ABCC1—Irinotecan—hematologic cancer	0.0199	0.0337	CbGbCtD
Atazanavir—ABCC1—Vinblastine—hematologic cancer	0.0177	0.0299	CbGbCtD
Atazanavir—CYP2C9—Bexarotene—hematologic cancer	0.0177	0.0298	CbGbCtD
Atazanavir—ABCC1—Vincristine—hematologic cancer	0.0174	0.0294	CbGbCtD
Atazanavir—ABCB1—Lenalidomide—hematologic cancer	0.0171	0.029	CbGbCtD
Atazanavir—ABCC1—Etoposide—hematologic cancer	0.016	0.027	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—hematologic cancer	0.0153	0.0258	CbGbCtD
Atazanavir—CYP2C9—Idarubicin—hematologic cancer	0.0146	0.0247	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—hematologic cancer	0.0109	0.0184	CbGbCtD
Atazanavir—CYP2C9—Bortezomib—hematologic cancer	0.0108	0.0183	CbGbCtD
Atazanavir—ABCC1—Methotrexate—hematologic cancer	0.0105	0.0178	CbGbCtD
Atazanavir—CYP3A4—Bexarotene—hematologic cancer	0.0103	0.0174	CbGbCtD
Atazanavir—ABCB1—Daunorubicin—hematologic cancer	0.0101	0.017	CbGbCtD
Atazanavir—ABCB1—Alitretinoin—hematologic cancer	0.00985	0.0166	CbGbCtD
Atazanavir—CYP3A4—Busulfan—hematologic cancer	0.00955	0.0161	CbGbCtD
Atazanavir—CYP3A4—Lomustine—hematologic cancer	0.00955	0.0161	CbGbCtD
Atazanavir—CYP2C9—Thalidomide—hematologic cancer	0.00943	0.0159	CbGbCtD
Atazanavir—CYP2C9—Teniposide—hematologic cancer	0.009	0.0152	CbGbCtD
Atazanavir—CYP3A4—Thiotepa—hematologic cancer	0.00851	0.0144	CbGbCtD
Atazanavir—CYP2C9—Ifosfamide—hematologic cancer	0.0083	0.014	CbGbCtD
Atazanavir—CYP2C9—Imatinib—hematologic cancer	0.00793	0.0134	CbGbCtD
Atazanavir—ABCB1—Imatinib—hematologic cancer	0.0077	0.013	CbGbCtD
Atazanavir—CYP2C9—Nilotinib—hematologic cancer	0.00721	0.0122	CbGbCtD
Atazanavir—ABCB1—Nilotinib—hematologic cancer	0.007	0.0118	CbGbCtD
Atazanavir—ABCB1—Vinorelbine—hematologic cancer	0.00694	0.0117	CbGbCtD
Atazanavir—CYP3A4—Methoxsalen—hematologic cancer	0.00662	0.0112	CbGbCtD
Atazanavir—CYP3A4—Bortezomib—hematologic cancer	0.0063	0.0106	CbGbCtD
Atazanavir—ABCB1—Dasatinib—hematologic cancer	0.00618	0.0104	CbGbCtD
Atazanavir—ABCB1—Mitoxantrone—hematologic cancer	0.00611	0.0103	CbGbCtD
Atazanavir—CYP3A4—Daunorubicin—hematologic cancer	0.00602	0.0102	CbGbCtD
Atazanavir—ABCB1—Betamethasone—hematologic cancer	0.00544	0.0092	CbGbCtD
Atazanavir—ABCB1—Gemcitabine—hematologic cancer	0.0054	0.00911	CbGbCtD
Atazanavir—ABCB1—Prednisolone—hematologic cancer	0.00537	0.00907	CbGbCtD
Atazanavir—CYP3A4—Cytarabine—hematologic cancer	0.00531	0.00897	CbGbCtD
Atazanavir—CYP3A4—Teniposide—hematologic cancer	0.00523	0.00884	CbGbCtD
Atazanavir—ABCB1—Prednisone—hematologic cancer	0.00507	0.00857	CbGbCtD
Atazanavir—CYP3A4—Ifosfamide—hematologic cancer	0.00483	0.00816	CbGbCtD
Atazanavir—ABCB1—Irinotecan—hematologic cancer	0.00481	0.00812	CbGbCtD
Atazanavir—CYP3A4—Imatinib—hematologic cancer	0.00461	0.00779	CbGbCtD
Atazanavir—CYP3A4—Ruxolitinib—hematologic cancer	0.00434	0.00734	CbGbCtD
Atazanavir—ABCB1—Vinblastine—hematologic cancer	0.00428	0.00722	CbGbCtD
Atazanavir—ABCB1—Vincristine—hematologic cancer	0.0042	0.0071	CbGbCtD
Atazanavir—CYP3A4—Nilotinib—hematologic cancer	0.00419	0.00708	CbGbCtD
Atazanavir—CYP3A4—Vinorelbine—hematologic cancer	0.00416	0.00702	CbGbCtD
Atazanavir—CYP2C9—Cisplatin—hematologic cancer	0.00404	0.00682	CbGbCtD
Atazanavir—ABCB1—Cisplatin—hematologic cancer	0.00392	0.00662	CbGbCtD
Atazanavir—ABCB1—Etoposide—hematologic cancer	0.00385	0.00651	CbGbCtD
Atazanavir—CYP3A4—Triamcinolone—hematologic cancer	0.0038	0.00642	CbGbCtD
Atazanavir—CYP3A4—Dasatinib—hematologic cancer	0.0037	0.00626	CbGbCtD
Atazanavir—CYP3A4—Mitoxantrone—hematologic cancer	0.00366	0.00618	CbGbCtD
Atazanavir—CYP2C9—Dexamethasone—hematologic cancer	0.00326	0.00551	CbGbCtD
Atazanavir—CYP3A4—Betamethasone—hematologic cancer	0.00326	0.00551	CbGbCtD
Atazanavir—CYP3A4—Prednisolone—hematologic cancer	0.00322	0.00544	CbGbCtD
Atazanavir—ABCB1—Dexamethasone—hematologic cancer	0.00317	0.00535	CbGbCtD
Atazanavir—CYP3A4—Prednisone—hematologic cancer	0.00304	0.00513	CbGbCtD
Atazanavir—CYP3A4—Irinotecan—hematologic cancer	0.00288	0.00487	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—hematologic cancer	0.00263	0.00444	CbGbCtD
Atazanavir—CYP3A4—Vinblastine—hematologic cancer	0.00256	0.00433	CbGbCtD
Atazanavir—ABCB1—Methotrexate—hematologic cancer	0.00254	0.0043	CbGbCtD
Atazanavir—CYP3A4—Vincristine—hematologic cancer	0.00252	0.00425	CbGbCtD
Atazanavir—CYP3A4—Etoposide—hematologic cancer	0.00231	0.0039	CbGbCtD
Atazanavir—CYP3A4—Dexamethasone—hematologic cancer	0.0019	0.00321	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—hematologic cancer	0.00157	0.00266	CbGbCtD
Atazanavir—Saquinavir—SLC22A1—hematologic cancer	0.000609	0.247	CrCbGaD
Atazanavir—Ritonavir—ABCG2—hematologic cancer	0.000561	0.227	CrCbGaD
Atazanavir—Saquinavir—ABCG2—hematologic cancer	0.000425	0.172	CrCbGaD
Atazanavir—Lopinavir—ABCB1—hematologic cancer	0.000278	0.113	CrCbGaD
Atazanavir—Ritonavir—ABCB1—hematologic cancer	0.000234	0.0946	CrCbGaD
Atazanavir—Saquinavir—ALB—hematologic cancer	0.000185	0.0751	CrCbGaD
Atazanavir—Saquinavir—ABCB1—hematologic cancer	0.000177	0.0717	CrCbGaD
Atazanavir—Infection—Prednisone—hematologic cancer	1.86e-05	7.66e-05	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—hematologic cancer	1.86e-05	7.65e-05	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.86e-05	7.64e-05	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.86e-05	7.64e-05	CcSEcCtD
Atazanavir—Back pain—Methotrexate—hematologic cancer	1.86e-05	7.63e-05	CcSEcCtD
Atazanavir—Fatigue—Dexamethasone—hematologic cancer	1.86e-05	7.63e-05	CcSEcCtD
Atazanavir—Fatigue—Betamethasone—hematologic cancer	1.86e-05	7.63e-05	CcSEcCtD
Atazanavir—Pruritus—Etoposide—hematologic cancer	1.85e-05	7.61e-05	CcSEcCtD
Atazanavir—Shock—Prednisone—hematologic cancer	1.85e-05	7.58e-05	CcSEcCtD
Atazanavir—Pain—Betamethasone—hematologic cancer	1.84e-05	7.57e-05	CcSEcCtD
Atazanavir—Pain—Dexamethasone—hematologic cancer	1.84e-05	7.57e-05	CcSEcCtD
Atazanavir—Nervous system disorder—Prednisone—hematologic cancer	1.84e-05	7.56e-05	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—hematologic cancer	1.83e-05	7.5e-05	CcSEcCtD
Atazanavir—Skin disorder—Prednisone—hematologic cancer	1.82e-05	7.49e-05	CcSEcCtD
Atazanavir—Nausea—Gemcitabine—hematologic cancer	1.82e-05	7.48e-05	CcSEcCtD
Atazanavir—Vomiting—Cisplatin—hematologic cancer	1.82e-05	7.46e-05	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisone—hematologic cancer	1.81e-05	7.45e-05	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—hematologic cancer	1.81e-05	7.43e-05	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—hematologic cancer	1.81e-05	7.42e-05	CcSEcCtD
Atazanavir—Rash—Cisplatin—hematologic cancer	1.8e-05	7.4e-05	CcSEcCtD
Atazanavir—Dermatitis—Cisplatin—hematologic cancer	1.8e-05	7.39e-05	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—hematologic cancer	1.8e-05	7.39e-05	CcSEcCtD
Atazanavir—Diarrhoea—Etoposide—hematologic cancer	1.79e-05	7.36e-05	CcSEcCtD
Atazanavir—Anorexia—Prednisone—hematologic cancer	1.79e-05	7.35e-05	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—hematologic cancer	1.79e-05	7.34e-05	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—hematologic cancer	1.78e-05	7.32e-05	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—hematologic cancer	1.78e-05	7.32e-05	CcSEcCtD
Atazanavir—Feeling abnormal—Dexamethasone—hematologic cancer	1.78e-05	7.29e-05	CcSEcCtD
Atazanavir—Feeling abnormal—Betamethasone—hematologic cancer	1.78e-05	7.29e-05	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—hematologic cancer	1.77e-05	7.29e-05	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—hematologic cancer	1.77e-05	7.28e-05	CcSEcCtD
Atazanavir—Tension—Epirubicin—hematologic cancer	1.77e-05	7.25e-05	CcSEcCtD
Atazanavir—Gastrointestinal pain—Betamethasone—hematologic cancer	1.76e-05	7.24e-05	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.76e-05	7.24e-05	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—hematologic cancer	1.76e-05	7.23e-05	CcSEcCtD
Atazanavir—Hypersensitivity—Triamcinolone—hematologic cancer	1.75e-05	7.19e-05	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—hematologic cancer	1.75e-05	7.17e-05	CcSEcCtD
Atazanavir—Back pain—Epirubicin—hematologic cancer	1.74e-05	7.14e-05	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—hematologic cancer	1.73e-05	7.12e-05	CcSEcCtD
Atazanavir—Malaise—Methotrexate—hematologic cancer	1.73e-05	7.12e-05	CcSEcCtD
Atazanavir—Dizziness—Etoposide—hematologic cancer	1.73e-05	7.11e-05	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—hematologic cancer	1.73e-05	7.09e-05	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—hematologic cancer	1.72e-05	7.08e-05	CcSEcCtD
Atazanavir—Urticaria—Dexamethasone—hematologic cancer	1.71e-05	7.03e-05	CcSEcCtD
Atazanavir—Urticaria—Betamethasone—hematologic cancer	1.71e-05	7.03e-05	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.71e-05	7.02e-05	CcSEcCtD
Atazanavir—Dizziness—Prednisolone—hematologic cancer	1.71e-05	7.01e-05	CcSEcCtD
Atazanavir—Asthenia—Triamcinolone—hematologic cancer	1.7e-05	7e-05	CcSEcCtD
Atazanavir—Body temperature increased—Betamethasone—hematologic cancer	1.7e-05	7e-05	CcSEcCtD
Atazanavir—Abdominal pain—Betamethasone—hematologic cancer	1.7e-05	7e-05	CcSEcCtD
Atazanavir—Body temperature increased—Dexamethasone—hematologic cancer	1.7e-05	7e-05	CcSEcCtD
Atazanavir—Abdominal pain—Dexamethasone—hematologic cancer	1.7e-05	7e-05	CcSEcCtD
Atazanavir—Nausea—Cisplatin—hematologic cancer	1.7e-05	6.97e-05	CcSEcCtD
Atazanavir—Insomnia—Prednisone—hematologic cancer	1.7e-05	6.97e-05	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—hematologic cancer	1.69e-05	6.94e-05	CcSEcCtD
Atazanavir—Pruritus—Triamcinolone—hematologic cancer	1.68e-05	6.9e-05	CcSEcCtD
Atazanavir—Cough—Methotrexate—hematologic cancer	1.68e-05	6.89e-05	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—hematologic cancer	1.68e-05	6.88e-05	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—hematologic cancer	1.67e-05	6.85e-05	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—hematologic cancer	1.67e-05	6.84e-05	CcSEcCtD
Atazanavir—Vomiting—Etoposide—hematologic cancer	1.67e-05	6.84e-05	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—hematologic cancer	1.66e-05	6.83e-05	CcSEcCtD
Atazanavir—Agitation—Epirubicin—hematologic cancer	1.65e-05	6.79e-05	CcSEcCtD
Atazanavir—Dyspepsia—Prednisone—hematologic cancer	1.65e-05	6.78e-05	CcSEcCtD
Atazanavir—Rash—Etoposide—hematologic cancer	1.65e-05	6.78e-05	CcSEcCtD
Atazanavir—Dermatitis—Etoposide—hematologic cancer	1.65e-05	6.77e-05	CcSEcCtD
Atazanavir—Headache—Etoposide—hematologic cancer	1.64e-05	6.74e-05	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—hematologic cancer	1.64e-05	6.73e-05	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—hematologic cancer	1.64e-05	6.72e-05	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—hematologic cancer	1.64e-05	6.72e-05	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—hematologic cancer	1.64e-05	6.72e-05	CcSEcCtD
Atazanavir—Tension—Doxorubicin—hematologic cancer	1.63e-05	6.71e-05	CcSEcCtD
Atazanavir—Decreased appetite—Prednisone—hematologic cancer	1.63e-05	6.7e-05	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—hematologic cancer	1.63e-05	6.69e-05	CcSEcCtD
Atazanavir—Rash—Prednisolone—hematologic cancer	1.63e-05	6.69e-05	CcSEcCtD
Atazanavir—Dermatitis—Prednisolone—hematologic cancer	1.63e-05	6.68e-05	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.63e-05	6.67e-05	CcSEcCtD
Atazanavir—Malaise—Epirubicin—hematologic cancer	1.62e-05	6.66e-05	CcSEcCtD
Atazanavir—Fatigue—Prednisone—hematologic cancer	1.62e-05	6.65e-05	CcSEcCtD
Atazanavir—Headache—Prednisolone—hematologic cancer	1.62e-05	6.64e-05	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—hematologic cancer	1.62e-05	6.64e-05	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—hematologic cancer	1.62e-05	6.64e-05	CcSEcCtD
Atazanavir—Syncope—Epirubicin—hematologic cancer	1.61e-05	6.62e-05	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—hematologic cancer	1.61e-05	6.61e-05	CcSEcCtD
Atazanavir—Constipation—Prednisone—hematologic cancer	1.61e-05	6.59e-05	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—hematologic cancer	1.59e-05	6.53e-05	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—hematologic cancer	1.58e-05	6.5e-05	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—hematologic cancer	1.58e-05	6.49e-05	CcSEcCtD
Atazanavir—Dizziness—Triamcinolone—hematologic cancer	1.57e-05	6.45e-05	CcSEcCtD
Atazanavir—Cough—Epirubicin—hematologic cancer	1.57e-05	6.45e-05	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—hematologic cancer	1.56e-05	6.4e-05	CcSEcCtD
Atazanavir—Infection—Methotrexate—hematologic cancer	1.56e-05	6.4e-05	CcSEcCtD
Atazanavir—Nausea—Etoposide—hematologic cancer	1.56e-05	6.39e-05	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—hematologic cancer	1.55e-05	6.38e-05	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisone—hematologic cancer	1.55e-05	6.35e-05	CcSEcCtD
Atazanavir—Asthenia—Dexamethasone—hematologic cancer	1.55e-05	6.35e-05	CcSEcCtD
Atazanavir—Asthenia—Betamethasone—hematologic cancer	1.55e-05	6.35e-05	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—hematologic cancer	1.54e-05	6.34e-05	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—hematologic cancer	1.54e-05	6.32e-05	CcSEcCtD
Atazanavir—Gastrointestinal pain—Prednisone—hematologic cancer	1.54e-05	6.3e-05	CcSEcCtD
Atazanavir—Nausea—Prednisolone—hematologic cancer	1.53e-05	6.3e-05	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—hematologic cancer	1.53e-05	6.29e-05	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—hematologic cancer	1.53e-05	6.29e-05	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—hematologic cancer	1.53e-05	6.29e-05	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—hematologic cancer	1.53e-05	6.28e-05	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—hematologic cancer	1.53e-05	6.27e-05	CcSEcCtD
Atazanavir—Pruritus—Dexamethasone—hematologic cancer	1.53e-05	6.26e-05	CcSEcCtD
Atazanavir—Pruritus—Betamethasone—hematologic cancer	1.53e-05	6.26e-05	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—hematologic cancer	1.52e-05	6.26e-05	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.52e-05	6.25e-05	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—hematologic cancer	1.52e-05	6.23e-05	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—hematologic cancer	1.51e-05	6.21e-05	CcSEcCtD
Atazanavir—Vomiting—Triamcinolone—hematologic cancer	1.51e-05	6.2e-05	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—hematologic cancer	1.5e-05	6.16e-05	CcSEcCtD
Atazanavir—Rash—Triamcinolone—hematologic cancer	1.5e-05	6.15e-05	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—hematologic cancer	1.5e-05	6.15e-05	CcSEcCtD
Atazanavir—Dermatitis—Triamcinolone—hematologic cancer	1.5e-05	6.14e-05	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—hematologic cancer	1.5e-05	6.14e-05	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—hematologic cancer	1.49e-05	6.13e-05	CcSEcCtD
Atazanavir—Urticaria—Prednisone—hematologic cancer	1.49e-05	6.12e-05	CcSEcCtD
Atazanavir—Headache—Triamcinolone—hematologic cancer	1.49e-05	6.11e-05	CcSEcCtD
Atazanavir—Abdominal pain—Prednisone—hematologic cancer	1.48e-05	6.09e-05	CcSEcCtD
Atazanavir—Body temperature increased—Prednisone—hematologic cancer	1.48e-05	6.09e-05	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—hematologic cancer	1.48e-05	6.08e-05	CcSEcCtD
Atazanavir—Diarrhoea—Dexamethasone—hematologic cancer	1.47e-05	6.06e-05	CcSEcCtD
Atazanavir—Diarrhoea—Betamethasone—hematologic cancer	1.47e-05	6.06e-05	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—hematologic cancer	1.47e-05	6.04e-05	CcSEcCtD
Atazanavir—Oedema—Epirubicin—hematologic cancer	1.47e-05	6.03e-05	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—hematologic cancer	1.46e-05	6.01e-05	CcSEcCtD
Atazanavir—Infection—Epirubicin—hematologic cancer	1.46e-05	5.99e-05	CcSEcCtD
Atazanavir—Cough—Doxorubicin—hematologic cancer	1.45e-05	5.96e-05	CcSEcCtD
Atazanavir—Shock—Epirubicin—hematologic cancer	1.44e-05	5.93e-05	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—hematologic cancer	1.44e-05	5.92e-05	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—hematologic cancer	1.44e-05	5.91e-05	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—hematologic cancer	1.44e-05	5.9e-05	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.43e-05	5.87e-05	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—hematologic cancer	1.43e-05	5.86e-05	CcSEcCtD
Atazanavir—Dizziness—Betamethasone—hematologic cancer	1.43e-05	5.85e-05	CcSEcCtD
Atazanavir—Dizziness—Dexamethasone—hematologic cancer	1.43e-05	5.85e-05	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—hematologic cancer	1.42e-05	5.83e-05	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—hematologic cancer	1.42e-05	5.83e-05	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—hematologic cancer	1.42e-05	5.82e-05	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—hematologic cancer	1.42e-05	5.82e-05	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—hematologic cancer	1.42e-05	5.82e-05	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—hematologic cancer	1.41e-05	5.8e-05	CcSEcCtD
Atazanavir—Nausea—Triamcinolone—hematologic cancer	1.41e-05	5.79e-05	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.41e-05	5.78e-05	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—hematologic cancer	1.4e-05	5.75e-05	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—hematologic cancer	1.4e-05	5.75e-05	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—hematologic cancer	1.4e-05	5.74e-05	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—hematologic cancer	1.39e-05	5.73e-05	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—hematologic cancer	1.39e-05	5.69e-05	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisone—hematologic cancer	1.38e-05	5.68e-05	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—hematologic cancer	1.38e-05	5.67e-05	CcSEcCtD
Atazanavir—Vomiting—Betamethasone—hematologic cancer	1.37e-05	5.63e-05	CcSEcCtD
Atazanavir—Vomiting—Dexamethasone—hematologic cancer	1.37e-05	5.63e-05	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—hematologic cancer	1.37e-05	5.62e-05	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—hematologic cancer	1.36e-05	5.6e-05	CcSEcCtD
Atazanavir—Rash—Dexamethasone—hematologic cancer	1.36e-05	5.58e-05	CcSEcCtD
Atazanavir—Rash—Betamethasone—hematologic cancer	1.36e-05	5.58e-05	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—hematologic cancer	1.36e-05	5.58e-05	CcSEcCtD
Atazanavir—Dermatitis—Betamethasone—hematologic cancer	1.36e-05	5.58e-05	CcSEcCtD
Atazanavir—Dermatitis—Dexamethasone—hematologic cancer	1.36e-05	5.58e-05	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.35e-05	5.56e-05	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—hematologic cancer	1.35e-05	5.55e-05	CcSEcCtD
Atazanavir—Headache—Betamethasone—hematologic cancer	1.35e-05	5.54e-05	CcSEcCtD
Atazanavir—Headache—Dexamethasone—hematologic cancer	1.35e-05	5.54e-05	CcSEcCtD
Atazanavir—Infection—Doxorubicin—hematologic cancer	1.35e-05	5.54e-05	CcSEcCtD
Atazanavir—Asthenia—Prednisone—hematologic cancer	1.35e-05	5.53e-05	CcSEcCtD
Atazanavir—Pain—Methotrexate—hematologic cancer	1.34e-05	5.51e-05	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.34e-05	5.49e-05	CcSEcCtD
Atazanavir—Shock—Doxorubicin—hematologic cancer	1.34e-05	5.49e-05	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—hematologic cancer	1.33e-05	5.47e-05	CcSEcCtD
Atazanavir—Pruritus—Prednisone—hematologic cancer	1.33e-05	5.45e-05	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—hematologic cancer	1.33e-05	5.45e-05	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—hematologic cancer	1.32e-05	5.42e-05	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—hematologic cancer	1.31e-05	5.39e-05	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—hematologic cancer	1.31e-05	5.37e-05	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—hematologic cancer	1.31e-05	5.36e-05	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—hematologic cancer	1.29e-05	5.32e-05	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—hematologic cancer	1.29e-05	5.31e-05	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—hematologic cancer	1.29e-05	5.31e-05	CcSEcCtD
Atazanavir—Diarrhoea—Prednisone—hematologic cancer	1.28e-05	5.27e-05	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.28e-05	5.27e-05	CcSEcCtD
Atazanavir—Nausea—Dexamethasone—hematologic cancer	1.28e-05	5.26e-05	CcSEcCtD
Atazanavir—Nausea—Betamethasone—hematologic cancer	1.28e-05	5.26e-05	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—hematologic cancer	1.28e-05	5.24e-05	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.27e-05	5.2e-05	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—hematologic cancer	1.27e-05	5.2e-05	CcSEcCtD
Atazanavir—Pain—Epirubicin—hematologic cancer	1.26e-05	5.16e-05	CcSEcCtD
Atazanavir—Constipation—Epirubicin—hematologic cancer	1.26e-05	5.16e-05	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—hematologic cancer	1.25e-05	5.12e-05	CcSEcCtD
Atazanavir—Dizziness—Prednisone—hematologic cancer	1.24e-05	5.1e-05	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—hematologic cancer	1.24e-05	5.09e-05	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—hematologic cancer	1.24e-05	5.09e-05	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.24e-05	5.08e-05	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—hematologic cancer	1.23e-05	5.04e-05	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—hematologic cancer	1.21e-05	4.97e-05	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—hematologic cancer	1.21e-05	4.97e-05	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—hematologic cancer	1.21e-05	4.96e-05	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—hematologic cancer	1.2e-05	4.93e-05	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—hematologic cancer	1.2e-05	4.91e-05	CcSEcCtD
Atazanavir—Vomiting—Prednisone—hematologic cancer	1.19e-05	4.9e-05	CcSEcCtD
Atazanavir—Rash—Prednisone—hematologic cancer	1.18e-05	4.86e-05	CcSEcCtD
Atazanavir—Dermatitis—Prednisone—hematologic cancer	1.18e-05	4.86e-05	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—hematologic cancer	1.18e-05	4.85e-05	CcSEcCtD
Atazanavir—Headache—Prednisone—hematologic cancer	1.18e-05	4.83e-05	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.17e-05	4.82e-05	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—hematologic cancer	1.17e-05	4.81e-05	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—hematologic cancer	1.17e-05	4.79e-05	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—hematologic cancer	1.16e-05	4.77e-05	CcSEcCtD
Atazanavir—Pain—Doxorubicin—hematologic cancer	1.16e-05	4.77e-05	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—hematologic cancer	1.16e-05	4.77e-05	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—hematologic cancer	1.16e-05	4.77e-05	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—hematologic cancer	1.16e-05	4.75e-05	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—hematologic cancer	1.13e-05	4.62e-05	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—hematologic cancer	1.12e-05	4.6e-05	CcSEcCtD
Atazanavir—Nausea—Prednisone—hematologic cancer	1.12e-05	4.58e-05	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.11e-05	4.56e-05	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—hematologic cancer	1.11e-05	4.56e-05	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—hematologic cancer	1.08e-05	4.44e-05	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—hematologic cancer	1.08e-05	4.43e-05	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—hematologic cancer	1.07e-05	4.41e-05	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—hematologic cancer	1.07e-05	4.41e-05	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—hematologic cancer	1.07e-05	4.41e-05	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—hematologic cancer	1.05e-05	4.33e-05	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—hematologic cancer	1.04e-05	4.26e-05	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—hematologic cancer	1.04e-05	4.26e-05	CcSEcCtD
Atazanavir—ABCC1—Disease—CDKN2B—hematologic cancer	1.02e-05	0.000284	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.02e-05	0.000284	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.02e-05	0.000283	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—MTHFR—hematologic cancer	1.01e-05	0.000282	CbGpPWpGaD
Atazanavir—Diarrhoea—Epirubicin—hematologic cancer	1e-05	4.12e-05	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—hematologic cancer	1e-05	4.11e-05	CcSEcCtD
Atazanavir—ABCC1—Metabolism—CYCS—hematologic cancer	1e-05	0.000279	CbGpPWpGaD
Atazanavir—Vomiting—Methotrexate—hematologic cancer	9.97e-06	4.1e-05	CcSEcCtD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	9.97e-06	0.000278	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HSP90AA1—hematologic cancer	9.94e-06	0.000277	CbGpPWpGaD
Atazanavir—Rash—Methotrexate—hematologic cancer	9.89e-06	4.06e-05	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—hematologic cancer	9.88e-06	4.06e-05	CcSEcCtD
Atazanavir—ABCB1—Metabolism—FHL2—hematologic cancer	9.87e-06	0.000275	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD86—hematologic cancer	9.87e-06	0.000275	CbGpPWpGaD
Atazanavir—Headache—Methotrexate—hematologic cancer	9.83e-06	4.04e-05	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—hematologic cancer	9.75e-06	4e-05	CcSEcCtD
Atazanavir—ABCC1—Disease—HES1—hematologic cancer	9.73e-06	0.000271	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	9.72e-06	0.000271	CbGpPWpGaD
Atazanavir—Dizziness—Epirubicin—hematologic cancer	9.71e-06	3.99e-05	CcSEcCtD
Atazanavir—ABCB1—Metabolism—AGRN—hematologic cancer	9.68e-06	0.00027	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NCOR1—hematologic cancer	9.68e-06	0.00027	CbGpPWpGaD
Atazanavir—Pruritus—Doxorubicin—hematologic cancer	9.61e-06	3.95e-05	CcSEcCtD
Atazanavir—ABCC1—Disease—FGF1—hematologic cancer	9.57e-06	0.000267	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	9.45e-06	0.000263	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FOXO1—hematologic cancer	9.43e-06	0.000263	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PDGFRB—hematologic cancer	9.41e-06	0.000262	CbGpPWpGaD
Atazanavir—Vomiting—Epirubicin—hematologic cancer	9.33e-06	3.83e-05	CcSEcCtD
Atazanavir—Nausea—Methotrexate—hematologic cancer	9.32e-06	3.83e-05	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—hematologic cancer	9.29e-06	3.82e-05	CcSEcCtD
Atazanavir—ABCC1—Disease—PDGFRA—hematologic cancer	9.27e-06	0.000258	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.26e-06	0.000258	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ASNS—hematologic cancer	9.26e-06	0.000258	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—DCK—hematologic cancer	9.26e-06	0.000258	CbGpPWpGaD
Atazanavir—Rash—Epirubicin—hematologic cancer	9.26e-06	3.8e-05	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—hematologic cancer	9.25e-06	3.8e-05	CcSEcCtD
Atazanavir—ABCC1—Disease—JAK1—hematologic cancer	9.23e-06	0.000257	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PRKCG—hematologic cancer	9.23e-06	0.000257	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—FHL2—hematologic cancer	9.22e-06	0.000257	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	9.21e-06	0.000257	CbGpPWpGaD
Atazanavir—Headache—Epirubicin—hematologic cancer	9.2e-06	3.78e-05	CcSEcCtD
Atazanavir—ABCB1—Metabolism—IDH2—hematologic cancer	9.18e-06	0.000256	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMMR—hematologic cancer	9.18e-06	0.000256	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AGRN—hematologic cancer	9.05e-06	0.000252	CbGpPWpGaD
Atazanavir—Dizziness—Doxorubicin—hematologic cancer	8.98e-06	3.69e-05	CcSEcCtD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.95e-06	0.000249	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.93e-06	0.000249	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTP1—hematologic cancer	8.82e-06	0.000246	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HDC—hematologic cancer	8.78e-06	0.000245	CbGpPWpGaD
Atazanavir—Nausea—Epirubicin—hematologic cancer	8.72e-06	3.58e-05	CcSEcCtD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	8.71e-06	0.000243	CbGpPWpGaD
Atazanavir—Vomiting—Doxorubicin—hematologic cancer	8.64e-06	3.55e-05	CcSEcCtD
Atazanavir—ABCB1—Metabolism—ARNTL—hematologic cancer	8.63e-06	0.000241	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMMR—hematologic cancer	8.58e-06	0.000239	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—IDH2—hematologic cancer	8.58e-06	0.000239	CbGpPWpGaD
Atazanavir—Rash—Doxorubicin—hematologic cancer	8.57e-06	3.52e-05	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—hematologic cancer	8.56e-06	3.51e-05	CcSEcCtD
Atazanavir—ABCC1—Disease—MTHFR—hematologic cancer	8.55e-06	0.000238	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.53e-06	0.000238	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TERT—hematologic cancer	8.53e-06	0.000238	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HLA-A—hematologic cancer	8.53e-06	0.000238	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	8.51e-06	0.000237	CbGpPWpGaD
Atazanavir—Headache—Doxorubicin—hematologic cancer	8.51e-06	3.49e-05	CcSEcCtD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	8.47e-06	0.000236	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.45e-06	0.000235	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CA9—hematologic cancer	8.4e-06	0.000234	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ACP5—hematologic cancer	8.4e-06	0.000234	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—hematologic cancer	8.35e-06	0.000233	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PDGFB—hematologic cancer	8.32e-06	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOR2—hematologic cancer	8.29e-06	0.000231	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TSC2—hematologic cancer	8.13e-06	0.000227	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—hematologic cancer	8.1e-06	0.000226	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NCOR1—hematologic cancer	8.1e-06	0.000226	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.09e-06	0.000225	CbGpPWpGaD
Atazanavir—Nausea—Doxorubicin—hematologic cancer	8.07e-06	3.31e-05	CcSEcCtD
Atazanavir—CYP2C9—Metabolism—ARNTL—hematologic cancer	8.06e-06	0.000225	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CDA—hematologic cancer	8.03e-06	0.000224	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—IDH1—hematologic cancer	7.89e-06	0.00022	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CREBBP—hematologic cancer	7.89e-06	0.00022	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	7.89e-06	0.00022	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ACP5—hematologic cancer	7.84e-06	0.000219	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CA9—hematologic cancer	7.84e-06	0.000219	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7.83e-06	0.000218	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGFR3—hematologic cancer	7.83e-06	0.000218	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCC3—hematologic cancer	7.81e-06	0.000218	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTO1—hematologic cancer	7.81e-06	0.000218	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TXN—hematologic cancer	7.81e-06	0.000218	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.74e-06	0.000216	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PC—hematologic cancer	7.73e-06	0.000215	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SPHK1—hematologic cancer	7.64e-06	0.000213	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	7.48e-06	0.000208	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.46e-06	0.000208	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GBA—hematologic cancer	7.46e-06	0.000208	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BAD—hematologic cancer	7.42e-06	0.000207	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—hematologic cancer	7.39e-06	0.000206	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—IDH1—hematologic cancer	7.37e-06	0.000205	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOTCH1—hematologic cancer	7.35e-06	0.000205	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—UGT1A1—hematologic cancer	7.34e-06	0.000204	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTO1—hematologic cancer	7.29e-06	0.000203	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCC3—hematologic cancer	7.29e-06	0.000203	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TXN—hematologic cancer	7.29e-06	0.000203	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD80—hematologic cancer	7.2e-06	0.000201	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.19e-06	0.0002	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KIT—hematologic cancer	7.18e-06	0.0002	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—hematologic cancer	7.16e-06	0.0002	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.14e-06	0.000199	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CRABP1—hematologic cancer	7.14e-06	0.000199	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SPHK1—hematologic cancer	7.14e-06	0.000199	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	7.06e-06	0.000197	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTPN11—hematologic cancer	7.06e-06	0.000197	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALOX5—hematologic cancer	6.96e-06	0.000194	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.96e-06	0.000194	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.86e-06	0.000191	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CREB1—hematologic cancer	6.84e-06	0.000191	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTAP—hematologic cancer	6.83e-06	0.00019	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—hematologic cancer	6.75e-06	0.000188	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NUP98—hematologic cancer	6.74e-06	0.000188	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6R—hematologic cancer	6.67e-06	0.000186	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.67e-06	0.000186	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.67e-06	0.000186	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CREBBP—hematologic cancer	6.66e-06	0.000186	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADCY7—hematologic cancer	6.54e-06	0.000182	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOA3—hematologic cancer	6.54e-06	0.000182	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	6.52e-06	0.000182	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.5e-06	0.000181	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NUP214—hematologic cancer	6.49e-06	0.000181	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTR—hematologic cancer	6.36e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG2—hematologic cancer	6.36e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAP2K1—hematologic cancer	6.36e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CD—hematologic cancer	6.32e-06	0.000176	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.31e-06	0.000176	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NUP98—hematologic cancer	6.29e-06	0.000175	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ENO2—hematologic cancer	6.24e-06	0.000174	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.11e-06	0.00017	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.11e-06	0.00017	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FHL2—hematologic cancer	6.08e-06	0.00017	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NUP214—hematologic cancer	6.07e-06	0.000169	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—hematologic cancer	6.05e-06	0.000169	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF2—hematologic cancer	6.05e-06	0.000169	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—hematologic cancer	6.02e-06	0.000168	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6e-06	0.000167	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AGRN—hematologic cancer	5.97e-06	0.000166	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3R1—hematologic cancer	5.96e-06	0.000166	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTR—hematologic cancer	5.94e-06	0.000166	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.94e-06	0.000166	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SDC1—hematologic cancer	5.92e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.87e-06	0.000164	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ENO2—hematologic cancer	5.83e-06	0.000162	CbGpPWpGaD
Atazanavir—ABCC1—Disease—JAK2—hematologic cancer	5.8e-06	0.000162	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.67e-06	0.000158	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MDM2—hematologic cancer	5.66e-06	0.000158	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—IDH2—hematologic cancer	5.66e-06	0.000158	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMMR—hematologic cancer	5.66e-06	0.000158	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.65e-06	0.000158	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTEN—hematologic cancer	5.63e-06	0.000157	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CREBBP—hematologic cancer	5.58e-06	0.000155	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.57e-06	0.000155	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SDC1—hematologic cancer	5.53e-06	0.000154	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CB—hematologic cancer	5.51e-06	0.000153	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTOR—hematologic cancer	5.51e-06	0.000153	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD4—hematologic cancer	5.49e-06	0.000153	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—EP300—hematologic cancer	5.37e-06	0.00015	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.32e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.3e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CD—hematologic cancer	5.29e-06	0.000147	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.28e-06	0.000147	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—hematologic cancer	5.22e-06	0.000146	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.21e-06	0.000145	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ACP5—hematologic cancer	5.17e-06	0.000144	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA9—hematologic cancer	5.17e-06	0.000144	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1B—hematologic cancer	5.17e-06	0.000144	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.11e-06	0.000142	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NQO1—hematologic cancer	5.03e-06	0.00014	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CD44—hematologic cancer	5.03e-06	0.00014	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3R1—hematologic cancer	4.99e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.98e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—IDH1—hematologic cancer	4.86e-06	0.000136	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.81e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.81e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TXN—hematologic cancer	4.81e-06	0.000134	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1A—hematologic cancer	4.77e-06	0.000133	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYCS—hematologic cancer	4.76e-06	0.000133	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTEN—hematologic cancer	4.76e-06	0.000133	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.73e-06	0.000132	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.71e-06	0.000131	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CD44—hematologic cancer	4.7e-06	0.000131	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NQO1—hematologic cancer	4.7e-06	0.000131	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CB—hematologic cancer	4.61e-06	0.000128	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.6e-06	0.000128	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EP300—hematologic cancer	4.54e-06	0.000126	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.52e-06	0.000126	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYCS—hematologic cancer	4.45e-06	0.000124	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.42e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SRC—hematologic cancer	4.41e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.4e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.4e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.29e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—hematologic cancer	4.25e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NRAS—hematologic cancer	4.24e-06	0.000118	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—hematologic cancer	4.19e-06	0.000117	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NUP98—hematologic cancer	4.15e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK3—hematologic cancer	4.06e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.03e-06	0.000112	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.03e-06	0.000112	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NUP214—hematologic cancer	4e-06	0.000112	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTEN—hematologic cancer	3.98e-06	0.000111	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.98e-06	0.000111	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	3.98e-06	0.000111	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—hematologic cancer	3.95e-06	0.00011	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFB1—hematologic cancer	3.94e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.92e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTR—hematologic cancer	3.92e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.92e-06	0.000109	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOR1—hematologic cancer	3.85e-06	0.000107	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—hematologic cancer	3.85e-06	0.000107	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ENO2—hematologic cancer	3.84e-06	0.000107	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—EP300—hematologic cancer	3.8e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.79e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.73e-06	0.000104	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.71e-06	0.000103	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—hematologic cancer	3.65e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SDC1—hematologic cancer	3.64e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.6e-06	0.0001	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.6e-06	0.0001	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—hematologic cancer	3.41e-06	9.49e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—hematologic cancer	3.36e-06	9.35e-05	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—hematologic cancer	3.25e-06	9.05e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.18e-06	8.87e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HRAS—hematologic cancer	3.1e-06	8.65e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NQO1—hematologic cancer	3.1e-06	8.64e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CD44—hematologic cancer	3.1e-06	8.64e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—hematologic cancer	2.97e-06	8.28e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYCS—hematologic cancer	2.93e-06	8.17e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.91e-06	8.12e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.86e-06	7.98e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—hematologic cancer	2.81e-06	7.83e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.8e-06	7.82e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—hematologic cancer	2.74e-06	7.64e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.67e-06	7.45e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CREBBP—hematologic cancer	2.65e-06	7.4e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.58e-06	7.2e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.52e-06	7.01e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—hematologic cancer	2.48e-06	6.92e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.48e-06	6.91e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.45e-06	6.82e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.38e-06	6.62e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.38e-06	6.62e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.38e-06	6.62e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.35e-06	6.55e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—hematologic cancer	2.32e-06	6.47e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—hematologic cancer	2.3e-06	6.4e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.22e-06	6.19e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.19e-06	6.11e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.1e-06	5.85e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.05e-06	5.71e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTEN—hematologic cancer	1.9e-06	5.28e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—EP300—hematologic cancer	1.81e-06	5.04e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTEN—hematologic cancer	1.77e-06	4.93e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.76e-06	4.91e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—EP300—hematologic cancer	1.69e-06	4.71e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.64e-06	4.56e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.55e-06	4.32e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—hematologic cancer	1.53e-06	4.26e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.46e-06	4.08e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.35e-06	3.77e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.34e-06	3.73e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.25e-06	3.48e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTEN—hematologic cancer	1.17e-06	3.25e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—EP300—hematologic cancer	1.11e-06	3.1e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—hematologic cancer	1.09e-06	3.04e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—hematologic cancer	1.02e-06	2.84e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.24e-07	2.3e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—hematologic cancer	6.73e-07	1.88e-05	CbGpPWpGaD
